No headlines found.
Globe Newswire (Fri, 10-Apr 8:15 AM ET)
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program
Globe Newswire (Tue, 31-Mar 8:45 AM ET)
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
Globe Newswire (Tue, 24-Mar 4:05 PM ET)
Globe Newswire (Mon, 16-Mar 8:00 AM ET)
LifeMD Reports Fourth Quarter and Full Year 2025 Results
Globe Newswire (Mon, 9-Mar 4:05 PM ET)
LifeMD to Participate in Two Investor Conferences During March
Globe Newswire (Tue, 3-Mar 4:05 PM ET)
LifeMD to Report Fourth Quarter 2025 Financial Results on March 9
Globe Newswire (Mon, 23-Feb 8:00 AM ET)
LifeMD, Inc. - 8.875% Series A Cumulative Perpetual Preferred Stock trades on the stock market under the symbol LFMDP.
As of April 10, 2026, LFMDP stock price climbed to $23.80 with 545 million shares trading.
LFMDP has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, LFMDP traded as high as $27.44 and as low as $13.40.
LFMDP has underperformed the market in the last year with a price return of +18.3% while the SPY ETF gained +25.2%. However, in the short term, LFMDP had mixed performance relative to the market. It has outperformed in the last 3 months, returning +9.2% vs -1.8% return in SPY. But in the last 2 weeks, LFMDP shares have been beat by the market, returning +3.8% compared to an SPY return of +5.3%.
LFMDP support price is $23.22 and resistance is $24.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFMDP shares will trade within this expected range on the day.
